Evidence
The evidence comparing in-hospital thrombolysis with PHT demonstrates clear superiority of PHT in reducing mortality [10]; widespread implementation of PHT has led to significantly improved performance against National Service Framework standards (call-to-needle and door-to-needle times). Bolus agents (reteplase or tenecteplase) are most suitable for the pre-hospital environment and are being administered promptly by paramedics in many parts of the UK.